Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison

We tested the hypothesis that long-term treatment with pomaglumetad methionil would demonstrate significantly less weight gain than aripiprazole in patients with schizophrenia. In this 24-week, multicenter, randomized, double-blind, Phase 3 study, 678 schizophrenia patients were randomized to either...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, David H., Zhang, Lu, Millen, Brian A., Kinon, Bruce J., Gomez, Juan-Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977437/
https://www.ncbi.nlm.nih.gov/pubmed/24772351
http://dx.doi.org/10.1155/2014/758212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977437/
https://www.ncbi.nlm.nih.gov/pubmed/24772351
http://dx.doi.org/10.1155/2014/758212

Ejemplares similares